Home › Nerve Sheath Cancer
Nerve Sheath Cancer clinical trials recruiting in the U.S.
5 studies for Nerve Sheath Cancer are recruiting participants at sites across the United States.
Recently updated studies
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07664397Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
RecruitingObservational study
Ages 3 to 120 · All sexes · Updated Sep 2, 2026 · NCT06222203NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RecruitingPhase 1/2
6 Months – 25 Years · All sexes · Updated Jun 30, 2026 · NCT06625190Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study
Recruiting
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT04278118From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.